Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis - Wikidata - awgldk - TriplyDB

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

http://www.wikidata.org/entity/Q26783356

about

Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study.Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy.

P2860

Q37116892-774FD3F9-7932-42E6-9ABF-5653D3831B79 Q47596523-65C09ABF-CDFC-46F9-89CC-C0D025DC74F5

P2860

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

http://www.wikidata.org/entity/Q26783356

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@ast

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@en

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@nl

type

label

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@ast

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@en

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@nl

prefLabel

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@ast

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@en

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@nl

P1433

Q26783356-DB397598-B73F-4C25-97F6-CC461D0708FA

P1476

Q26783356-4086958C-D2EA-4D67-94A4-14397CE67534

P2093

Q26783356-266FFA38-0640-4EB5-896C-4D729600030E

Q26783356-60142AC7-633A-4F59-A9EC-F7B6C90B5114

Q26783356-A6BE414A-3DA2-44ED-95ED-A85333077BA1

P2860

Q26783356-00FF547B-D5C5-40C8-A8E6-4BC42E83E9CA

Q26783356-05451B9E-0D54-4F1D-99F0-1EAC383C989E

Q26783356-07A624E0-A0BA-4DEF-A02C-C7617937CAC7

Q26783356-1215674E-572F-4163-9C5E-8B73D20A80AE

Q26783356-294028FD-0E16-4561-B55E-692E4F7823D8

Q26783356-3C8181D4-9454-4EB6-99AA-9BB551195BDC

Q26783356-462FEED8-A024-4C24-BCD9-690CA9812B98

Q26783356-46320C92-04EC-4CED-A766-9AF21E4711BE

Q26783356-51EB2873-27A1-4DC1-8A70-166231F8CF3F

Q26783356-55FF9A45-69F2-4A3D-8B30-D380B99CC44A

P304

Q26783356-B735299B-0037-4AD1-930A-B9842D1C3498

P31

Q26783356-74294078-90F8-48D8-AB3A-F14BAED28464

P3181

Q26783356-57734E1C-4050-44E3-A52E-30F7F11D03AB

P356

Q26783356-B824EC18-29DB-42A9-B059-1C4C568D83AF

P407

Q26783356-00D4B873-9809-4BE8-82EE-BB541D89963D

P433

Q26783356-6652F39C-C689-4343-B80F-A213D205E0AF

P478

Q26783356-07B84C10-049B-437C-8355-7F210C51BE06

P577

Q26783356-7B4E0C7C-47FC-41D4-9871-68DD252D1D15

P698

Q26783356-EC837D1D-8135-4E60-8C88-35B2A7DC221E

P921

Q26783356-A063051E-5813-4E0B-9A29-BC89284B9AC0

Q26783356-D01C2679-3993-4A94-B9C5-9025F5ED88BF

P932

Q26783356-DC0646B4-7F41-40BE-B718-614D0CAFBEDE

P3181

P356

WJH.V7.I22.2404

P1433

World journal of hepatology

P1476

Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis

@en

P2093

Kazunari Murakami

http://www.w3.org/2001/XMLSchema#string

Koichi Honda

http://www.w3.org/2001/XMLSchema#string

Masataka Seike

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of viral hepatitis and hepatocellular carcinoma

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis.

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis

Viral hepatitis B.

Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis.

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

P304

2404-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4695748

http://www.w3.org/2001/XMLSchema#string

P356

10.4254/WJH.V7.I22.2404

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26464756

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

4598611

http://www.w3.org/2001/XMLSchema#string